According to Parexel, the new depot in Singapore and ancillary warehouse in Russia will support its clients in more effectively managing their global clinical trial supply requirements.
The new depot in Singapore handles the distribution of investigational medicinal products and non-investigational medicinal products, as well as ancillary supplies needed for clinical trials conducted by Parexel.
However, the company’s new ancillary warehouse in Russia is intended to store any non-drug material required for clinical trials in Russia, including lab kits, drug application material, and medical supplies and equipment, as well as documents, such as patient diaries and questionnaires.
The new facilities feature 24/7/365 monitoring systems, and provide a number of services to Parexel’s clients including inventory management, as well as return and destruction capabilities.
Parexel Clinical Research Services corporate vice president Joe Avellone said the opening of these new facilities within their global Clinical Logistics Services infrastructure positions them to meet increasing client demand for high quality clinical trial supplies handling and transport in emerging regions.